• 27TH SEPTEMBER 2023

    Review and challenge disallowed items via MYS

    A disallowed item is one that has NOT been passed for payment by the NHS Business Services Authority (NHSBSA). Please check your disallowed items history on Manage Your Service (MYS) portal to identify the list of unpaid items and reasons why the item was disallowed by the NHSBSA. If you believe an item has been

    Read more
    • 26TH SEPTEMBER 2023

    MHRA Drug Safety Update: September 2023

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 2 September 2023) has been published and includes articles on: Statins: very infrequent reports of myasthenia gravis Fluoroquinolone antibiotics: suicidal thoughts and behaviour Letters and medicine recalls sent to healthcare professionals in August 2023. To see the latest MHRA Drug

    Read more
    • 26TH SEPTEMBER 2023

    October 2023 Category M prices announced

    The Drug Tariff Category M pricelist for October 2023 has been published on the NHS Business Services Authority (NHSBSA) website. At the end of Q4 2022/23 there remains an over delivery of medicine margin. The October Category M pricelist includes: Adjustments for underlying market price movements in the reference period April-June 2023. Of particular note is

    Read more
    • 25TH SEPTEMBER 2023

    Celebrating World Pharmacists Day 2023

    Pharmacy press As today marks World Pharmacists Day, an annual awareness day led by the International Pharmaceutical Federation (FIP) – we, at Community Pharmacy England, celebrating the crucial role pharmacists play in improving access to healthcare, ensuring the responsible use of medicines and so much more. This year’s theme, ‘Pharmacy strengthening health systems’, highlights the

    Read more
    • 21ST SEPTEMBER 2023

    Medicine Supply Notification: Hyoscine hydrobromide (Scopoderm® ) 1.5mg patches

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Hyoscine hydrobromide (Scopoderm®) 1.5mg patches. MSN/2023/087 Tier 2 – medium impact Date of issue 21st September 2023 Hyoscine hydrobromide (Scopoderm®) 1.5mg patches are in limited supply until w/c 1st January 2024. Alternative formulations of hyoscine hydrobromide remain available and will be

    Read more